Two recently published meta-analyses investigating inflammatory biomarkers in blood reported an elevated tumor necrosis factor (TNF)-α, IL-12 [191], IL-1β, IL-2, IL-6, IL-18 [191,192], and reduced IL-1 receptor antagonist concentration in AD patients compared with controls. This evidence concerns the gene IL6 and Alzheimer disease.